NHLBI Seeks CHIP Patients

NHLBI seeks patients with clonal hematopoiesis of indeterminate potential (CHIP). Patients with CHIP have a genetic mutation that has been associated with blood cancer. The study will look at CHIP and try to determine its relationship to blood cancers and heart disease. The study will also try to discover other new organs or diseases that may be linked with CHIP. There is no charge for study-related tests, medications or procedures. Travel assistance may be provided. For more information about study 19-H-0139, call 866-444-2214 or (800) 877-8339 TTY/ASCII. Read more online at https://go.usa.gov/xpYyx.

CCUS Patients Sought

NHLBI seeks patients with clonal cytopenia of undetermined significance (CCUS). Patients with CCUS have low blood counts and a normal bone marrow exam but more advanced genetic testing shows the presence of a genetic mutation that is likely causing the low counts. The study will look at CCUS and try to determine its relationship to blood cancers and heart disease. The study will also try to discover other new organs or diseases it may be linked with. There is no charge for study-related tests, medications or procedures. Travel assistance may be provided. For more information about study 19-H-0139, call 866-444-2214, (800) 877-8339 TTY/ASCII or visit https://go.usa.gov/xpYyx.